Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 11
1984 3
1985 4
1986 1
1987 4
1988 6
1989 2
1990 3
1991 1
1992 1
1994 1
1995 1
1997 1
2006 2
2007 1
2016 1
2017 4
2018 1
2019 3
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators. von Minckwitz G, et al. N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. N Engl J Med. 2017. PMID: 28581356 Free PMC article. Clinical Trial.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.
Swain SM, Miles D, Kim SB, Im YH, Im SA, Semiglazov V, Ciruelos E, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J; CLEOPATRA study group. Swain SM, et al. Lancet Oncol. 2020 Apr;21(4):519-530. doi: 10.1016/S1470-2045(19)30863-0. Epub 2020 Mar 12. Lancet Oncol. 2020. PMID: 32171426 Clinical Trial.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Peritoneal sarcoidosis.
Santolaria-Fernández F, Hernández-Marrero D, González-Reimers E, Batista-López N. Santolaria-Fernández F, et al. Among authors: batista lopez n. Arch Intern Med. 1988 Jan;148(1):233, 237. doi: 10.1001/archinte.1988.00380010235026. Arch Intern Med. 1988. PMID: 3337598 No abstract available.
[Peritoneal sarcoidosis].
Santolaria Fernández F, González Reimers E, Jorge Hernández JA, Batista López N, Pérez Labajos P, Martín Herrera A, Cubillo Ferreira G, Hernández Nieto L. Santolaria Fernández F, et al. Among authors: batista lopez n. Rev Clin Esp. 1981 Jan 15;160(1):63-4. Rev Clin Esp. 1981. PMID: 7209053 Spanish. No abstract available.
[Peritoneal mesothelioma].
González Reimers E, Fernández Herrero MD, Santolaria Fernández F, Batista López N, Conde Martel A. González Reimers E, et al. Among authors: batista lopez n. Rev Esp Enferm Dig. 1992 Jun;81(6):434. Rev Esp Enferm Dig. 1992. PMID: 1633022 Spanish. No abstract available.
Plasma levels of trastuzumab in gastric cancer: Case report.
González-García J, Alonso-Alvarez B, Nazco-Casariego GJ, Batista-López N, Guttiérrez-Nicolás F. González-García J, et al. Among authors: batista lopez n. J Oncol Pharm Pract. 2017 Dec;23(8):635-637. doi: 10.1177/1078155216670228. Epub 2016 Sep 23. J Oncol Pharm Pract. 2017. PMID: 27664112
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients.
Cuyàs E, Fernández-Arroyo S, Buxó M, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Verdura S, Brunet J, López-Bonet E, Garcia M, Saidani S, Joven J, Martin-Castillo B, Menendez JA. Cuyàs E, et al. Among authors: batista lopez n. Aging (Albany NY). 2019 May 9;11(9):2874-2888. doi: 10.18632/aging.101960. Aging (Albany NY). 2019. PMID: 31076561 Free PMC article. Clinical Trial.
Alcohol-induced hypogonadism: reversal after ethanol withdrawal.
Castilla-García A, Santolaria-Fernández FJ, González-Reimers CE, Batista-López N, González-García C, Jorge-Hernández JA, Hernández-Nieto L. Castilla-García A, et al. Among authors: batista lopez n. Drug Alcohol Depend. 1987 Nov 30;20(3):255-60. doi: 10.1016/0376-8716(87)90035-4. Drug Alcohol Depend. 1987. PMID: 3125031
Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer.
Lopez-Bonet E, Buxó M, Cuyàs E, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Oliveras G, Meléndez C, Castillo L, Verdura S, Brunet J, Joven J, Garcia M, Saidani S, Martin-Castillo B, Menendez JA. Lopez-Bonet E, et al. Among authors: batista lopez n. J Clin Med. 2019 Dec 11;8(12):2180. doi: 10.3390/jcm8122180. J Clin Med. 2019. PMID: 31835708 Free PMC article.
52 results